Question Does the addition of inotuzumab ozogamicin (InO) to dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (DA-EPOCH) result in a safe and effective treatment for adults with relapsed or refra
read more..